CAC 40
7 479,40 -51,32 (-0,68 %) Euro Stoxx 50
4 894,02 -8,58 (-0,18 %) Dow Jones
39 118,86 -45,24 (-0,12 %) EUR/USD
1,0749 +0,0040 (+0,38 %) Gold future
2 336,90 -2,70 (-0,12 %) Bitcoin EUR
57 535,53 +863,55 (+1,52 %)
ConvaTec Group PLC (CTEC.L)
ConvaTec Group PLC
20 Eastbourne Terrace
7th Floor
London W2 6LG
United Kingdom
https://www.convatecgroup.com
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 10 136
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Karim Bitar | CEO & Director | 2,97M | S.O. | 1965 |
| Mr. Jonathan Peter Mason | Group CFO & Director | 1,59M | S.O. | 1964 |
| Mr. John Haller | Executive VP and Chief Quality & Operations Officer | S.O. | S.O. | S.O. |
| Dr. Divakar Ramakrishnan Ph.D. | Executive VP, Chief Technology Officer and Head of Research & Development | S.O. | S.O. | S.O. |
| Ms. Kate Postans | Vice President of Investor Relations & Corporate Communications | S.O. | S.O. | S.O. |
| Ms. Evelyn Douglas J.D. | Executive VP, Chief of Corporate Strategy & Business Development and General Counsel | S.O. | S.O. | S.O. |
| Ms. Moyra Withycombe | Interim Chief People Officer | S.O. | S.O. | S.O. |
| Ms. Kjersti Grimsrud Biotechnology, M.Sc. | President & COO of Infusion Care | S.O. | S.O. | 1961 |
| Mr. David Shepherd | President & COO of Global Advanced Wound Care | S.O. | S.O. | S.O. |
| Mr. Seth R. Segel | President and COO of Continence Care & Home Services Group | S.O. | S.O. | 1969 |
Description
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Gouvernance d’entreprise
L’ISS Governance QualityScore de ConvaTec Group PLC en date du 29 juin 2024 est 2. Les scores principaux sont Audit : 3; Société : 3; Droits des actionnaires : 1; Compensation : 1.
